ArticleTropical medicine & international health : TM & IH2026
Strong Cross-Reactivity of Anti-Plasmodium falciparum pLDH Monoclonal Antibodies With Plasmodium malariae pLDH in the Abbott Bioline Malaria Ag P.f/P.f/P.v Rapid Diagnostic Test.
Article in Tropical medicine & international health : TM & IH, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectivesThis study aimed to describe the cross-reactivity of the Abbott Bioline Malaria Ag P.f/P.f/P.v rapid diagnostic test, designed to detect Plasmodium falciparum and P. vivax , with other Plasmodium species, based on the detection of parasite lactate dehydrogenase enzymes.
methodsBlood samples from 40 patients with positive thick and thin blood smear results were analysed: 10 infected with P. falciparum, 10 with P. vivax , 15 with P. malariae and five with P. ovale . Parasitemia was quantified as parasites/μL of blood. All samples were tested using the Abbott Bioline Malaria Ag P.f/P.f/P.v RDT, and species identification was confirmed by nested PCR. To compare test line intensities and assess potential nonspecific reactions, images of the RDT lines were analysed using ImageJ software. For statistical analyses, PCR was considered the gold standard. Sensitivity, specificity and accuracy were calculated using MedCalc 2026. Fisher's exact test was applied using GraphPad/Quick Calcs to compare the specificity of the anti-Pf-pLDH antibodies, with a significance level of 0.05 (p < 0.05).
resultsThe RDT accurately detected all P. falciparum and P. vivax samples. However, 12 of 14 P. malariae samples yielded positive results on the T2 line, intended to be specific for Pf-pLDH, as did four P. ovale isolates. The specificity of the anti-Pf-pLDH monoclonal antibodies against P. malariae was only 14.29% (p < 0.05). ImageJ analysis showed that the T2 line signal intensity in P. malariae-infected samples exceeded that observed in P. falciparum-infected samples.
conclusionsThis study provides the first evidence of cross-reactivity of anti-Pf-pLDH monoclonal antibodies in the Abbott Bioline Malaria Ag P.f/P.f/P.v RDT with P. malariae and P. ovale isolates. Moreover, highlights the imperative need to validate alternative biomarkers and novel point-of-care platforms, to enhance the rapid and accurate diagnosis of malaria, ensure species-specific treatment and ultimately support effective malaria control and elimination strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.